Fresenius Medical Care AG & Co., the world’s largest provider of dialysis equipment and related services, has agreed to pay U.S. authorities nearly $232 million to resolve allegations that it bribed doctors and health officials in some 17 countries in order to obtain business.
The German company also agreed to hire an independent compliance monitor for two years, remove 10 employees involved in the schemes, enhance its compliance program, adopt heightened controls on selecting third-party agents and withdraw from pending public contracts potentially related to the misconduct, according to the nonprosecution agreement the company signed with the U.S. Department of Justice.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]